PITTSBURGH--(BUSINESS WIRE)--Pittsburgh based Lipella Pharmaceuticals Inc. today announced newly published results of a multi-site, double-blind, placebo-controlled clinical trial comparing the ...
PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a clinical ...
DelveInsight Business Research's latest analysis highlights the significant impact of the FDA's approval of Pfizer and BioNTech's updated COMIRNATY LP.8.1-adapted monovalent COVID-19 vaccine on August ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback